Colgate-Palmolive (NYSE:CL – Get Free Report) had its price target dropped by analysts at Stifel Nicolaus from $95.00 to $93.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “hold” rating on the stock. Stifel Nicolaus’ price objective indicates a potential upside of 7.44% from the stock’s current price.
CL has been the subject of several other reports. Morgan Stanley cut their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a report on Monday. Raymond James reissued an “outperform” rating and issued a $105.00 target price (down from $110.00) on shares of Colgate-Palmolive in a report on Monday. JPMorgan Chase & Co. dropped their price target on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday, January 16th. Piper Sandler reduced their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. Finally, UBS Group lowered their target price on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $101.16.
Get Our Latest Research Report on CL
Colgate-Palmolive Stock Down 0.5 %
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the business posted $0.87 EPS. Equities analysts forecast that Colgate-Palmolive will post 3.74 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently bought and sold shares of CL. Chicago Partners Investment Group LLC increased its position in shares of Colgate-Palmolive by 16.2% in the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after buying an additional 943 shares in the last quarter. Peak Financial Advisors LLC acquired a new position in Colgate-Palmolive in the fourth quarter valued at about $1,315,000. Gordian Advisors LLC bought a new stake in shares of Colgate-Palmolive in the third quarter worth about $602,000. Carrera Capital Advisors raised its stake in Colgate-Palmolive by 23.1% in the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock valued at $4,066,000 after acquiring an additional 7,353 shares during the period. Finally, Fiduciary Alliance LLC acquired a new stake in Colgate-Palmolive during the 4th quarter valued at $4,066,000. Institutional investors own 80.41% of the company’s stock.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- P/E Ratio Calculation: How to Assess Stocks
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Following Congress Stock Trades
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.